DERMATA THERAPEUTICS, INC.

DRMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Aug 18, 2026 4
4 Aug 18, 2026 4
25-NSE Aug 17, 2026
8-K Aug 17, 2026 8-K
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
8-K Aug 5, 2026 8-K
4 Jun 16, 2026 4
S-8 Jun 4, 2026 S-8
SCHEDULE 13D Jun 1, 2026
EFFECT May 29, 2026
424B3 May 29, 2026 424B3
8-K May 27, 2026 8-K
CORRESP May 27, 2026
S-3/A May 22, 2026 S-3/A
SCHEDULE 13G/A May 13, 2026
10-Q May 13, 2026 10-Q
8-K May 13, 2026 8-K
SCHEDULE 13G/A Apr 22, 2026
ARS Apr 17, 2026 ARS
DEFA14A Apr 17, 2026 DEFA14A
DEF 14A Apr 17, 2026 DEF 14A
PRE 14A Apr 7, 2026 PRE 14A
10-K Mar 26, 2026 10-K
8-K Mar 26, 2026 8-K
← Newer Page 1 of 15 · 366 filings Older →